The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 26 of the 27 sources its claims cite were checked for support.
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Open accessAbstract
The extent of microglial heterogeneity in humans remains a central yet poorly explored question in light of the development of therapies targeting this cell type. Here, we investigate the population structure of live microglia purified from human cerebral cortex samples obtained at autopsy and during neurosurgical procedures. Using single cell RNA sequencing, we find that some subsets are enriched for disease-related genes and RNA signatures. We confirm the presence of four of these microglial subpopulations histologically and illustrate the utility of our data by characterizing further microglial cluster 7, enriched for genes depleted in the cortex of individuals with Alzheimer’s disease (AD). Histologically, these cluster 7 microglia are reduced in frequency in AD tissue, and we validate this observation in an independent set of single nucleus data. Thus, our live human microglia identify a range of subtypes, and we prioritize one of these as being altered in AD.
Overview
CoChat Summary
TL;DR
Single-cell RNA sequencing of live human microglia identified nine microglial subpopulations, including an antigen-presenting cluster 7 enriched for Alzheimer’s disease-related genes. Cluster 7 microglia were reduced in frequency in AD tissue histologically and in an independent single-nucleus dataset.
Key findings
- From 16,242 cells, the study identified 14 clusters, including 9 microglial subpopulations; 99.1% of isolated cells expressed microglial marker genes, and clusters were found in both autopsy DLPFC and surgical temporal cortex samples.
- Cluster 7 was enriched for antigen presentation, the murine DAM signature, and AD-related genes; its signature was reduced in AD cortex. Histologically, IBA1+CD74high microglia were reduced in AD versus control subjects (p = 0.0089), with no change in total IBA1+ cells (p = 0.30), and an independent single-nucleus dataset replicated reduced cluster 7 frequency in AD (p = 0.028).
- In situ validation showed subset marker frequencies: ISG15+ averaged 4.38% (SD = 1.83) of CD45+ cells, CD83+ averaged 1.98% (SD = 2.46) of IBA1+ cells, CD74high averaged 4.60% (SD = 0.33) of microglia, and PCNA+ averaged 4.55% (SD = 4.00) of microglia.
- Functional annotation linked cluster 4 to interferon response, cluster 9 to cell cycle/proliferation, clusters 5/6 to anti-inflammatory responses, and cluster 7 to antigen presentation; the murine DAM signature was distributed across clusters 4, 5, 7, and 8 rather than confined to one human cluster.
Methods
- Live microglia were purified from 14 MAP autopsy DLPFC samples and 3 temporal cortex surgical samples from epilepsy patients, then profiled with 10x Genomics Chromium 3′ scRNA-seq on HiSeq4000; after QC, 16,242 cells were clustered using iterative PCA-Louvain clustering with random forest-based robustness assessment and batch correction.
- Validation used immunohistochemistry on DLPFC sections with ISG15, CD83, CD74, and PCNA co-labeled with IBA1 or CD45, quantified by CellProfiler; disease/trait enrichment used DOSE and ROSMAP bulk RNA-seq traits, and an independent single-nucleus dataset was mapped to the clusters via canonical correlation analysis and a Naïve Bayes classifier.
Limitations
- The paper states possible survival bias among microglial subpopulations during live-cell isolation, loss of topological information, sampling of only two cortical regions, and that most disease analyses are indirect enrichment analyses needing direct confirmation in larger samples.
- The paper notes that batch correction regressed out batch identity and total UMIs, likely removing some biological signal and potentially reducing observed gene-expression diversity across donors and samples.
- The text makes evident that sample groups differ by age, brain region, disease condition, and autopsy versus surgery, so cluster-proportion differences cannot be unambiguously attributed; the authors also state they had too few subjects for robust direct disease association testing.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
14 Valid · 3 Not valid · 2 Not checked · 126 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The human microglia clusters 4, 5, and 7 showed the strongest enrichment for the signature associated with the murine DAM phenotype.”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Annotating the clusters of human microglia
What the sources say
- Could not verifycites [24] Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e1217 (2017). sourceExperimental — accuracy not yet measured
The Results describe murine DAM clusters II and III and report Lpl-positive microglia near plaques in human AD brain slices. They do not report human microglia clusters 4, 5, and 7 or compare their enrichment for the murine DAM signature (searched for those cluster numbers and human single-cell signature enrichment). (LLM, conf=0.72)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We then replicate this observation by repurposing DLPFC single nucleus RNA sequencing data generated from an independent set of MAP subjects9.”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Introduction
What the sources say
- Partly supportedcites [9] Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570, 332–337 (2019). sourceExperimental — accuracy not yet measured
The single-nucleus RNA-seq profiling section reports data from 48 Religious Order Study participants, so the cited paper does provide a dataset of the kind repurposed. But it identifies the sampled region as prefrontal cortex (Brodmann area 10), not DLPFC, and does not establish that these were an independent set of MAP subjects. The replication is the citing authors’ own analysis, not a result reported by this source. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“we see a significant (p = 5.3 × 10−70) excess of mouse homeostatic cells in human microglial cluster 1.”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Annotating the clusters of human microglia
What the sources say
- Could not verifycites [22] Mathys, H. et al. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 21, 366–380 (2017). sourceExperimental — accuracy not yet measured
The Results section on microglial cell states identifies homeostatic mouse microglia in the paper’s cluster 2, but does not report an excess of those cells in a human microglial cluster. The Results section comparing mouse and human microglia examines age-related gene expression, not the claimed cluster enrichment. Searches for human cluster 1 and p = 5.3 × 10−70 found no passage addressing that result; the paper’s mouse cluster numbering does not contradict a separately defined human cluster 1. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent publication9 generated single-nucleus RNA-seq data from dorsolateral prefrontal cortex in 48 donors (comprising subsets of donors with and without diagnoses of Alzheimer’s disease) from the ROSMAP cohort”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Methods > Mapping of single-nuclei data to single-cell clusters
What the sources say
- Partly supportedcites [9] Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570, 332–337 (2019). sourceExperimental — accuracy not yet measured
The section “Single-nucleus RNA-seq profiling of prefrontal cortex in human subjects with AD pathology” reports snRNA-seq profiles from prefrontal cortex tissue in 48 ROSMAP participants. It specifies Brodmann area 10, not dorsolateral prefrontal cortex; it also defines the two donor groups by AD pathology rather than diagnosis. (LLM, conf=0.88)
plainn = 48- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“While certain murine transcriptional programs – such as the DAM signature24 or the interferon response signature22 – are seen in our human microglia, they are distributed across different clusters”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Discussion
What the sources say
- Supportedcites [24] Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e1217 (2017). source
The Results describe a DAM gene-expression signature in microglia from 5XFAD mice (passages 6–7). The citation identifies the murine DAM signature; the observation that it appears across clusters of human microglia is the citing authors’ own finding. (LLM, conf=0.91)
- Supportedcites [22] Mathys, H. et al. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 21, 366–380 (2017). source
The Results section, “Heterogeneous Late Response of Microglia to Neurodegeneration,” identifies a co-regulated antiviral and interferon-response gene set in murine microglia. This supports the source’s role as the reference for the interferon-response signature (citation 22); the observation about its distribution across human clusters is the citing authors’ own finding. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
81 more claims · 1 with their cited sources checked
Create a free account to see all 145 claims and every source verdict.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 40
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These opposing states are accompanied by broad changes in gene expression12–17, suggesting that defined transcriptional programs in microglia may govern their neuroprotective or neurotoxic functions.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial lymphoid gene expression in PU.1low disease-associated microglia (DAM) is not restricted to mice but is also observed in individuals with AD15 (Fig. 2e and Supplementary Fig. 5).”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent progress in single-cell deep sequencing methods allowed for more refined differentiation and revealed regional-, age- and sex-dependent differences of the microglial population, and a growing number of studies demonstrate various expression profiles defining microglial subpopulations.”
From Beyond Activation: Characterizing Microglial Functional Phenotypes (2021) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an analysis of 16,096 individual microglial transcriptomes, the cluster depicting a distinct upregulation of CD68 was most enriched for DAM genes, such as CD74, HL-DRB1 and ITM2B and was associated with pathologic conditions, such as inflammatory demyelination, ischemia and AD [39].”
From Beyond Activation: Characterizing Microglial Functional Phenotypes (2021) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent experiments using deep sequencing revealed differences not only depending on the brain region, but also on age, gender, and pathology [28,39,99,102,108,109].”
From Beyond Activation: Characterizing Microglial Functional Phenotypes (2021) · cites this paper as [39]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Nature and distribution of the single-cell RNA sequencing data
“Significance was assessed using the (non-parametric) Mann–Whitney test, resulting in the p-values shown for each cluster.”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Methods > Cluster enrichment by sample condition
“we ran a non-parametric Kruskal–Wallis test with Benjamini–Hochberg correction to identify which clusters showed differential proportions across the three regions.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Discussion
“The clusters are also found in single nucleus data (Supplementary Fig. 14), consistent with the fact that our purification protocol does not appear to lose a specific microglial subtype.”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Assessing the relation of IBA1+CD74high cells to AD
“these microglial nuclei are distributed to all of our clusters, except for the proliferative cluster 9.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Assessing the relation of IBA1+CD74high cells to AD
“Adjusting for age and gender, we find that subjects with AD (1) have a significant reduction in the frequency of IBA1+CD74high microglial cells in the frontal cortex (p = 0.0089; Fig. 8d)”
§ Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease > Results > Disease and trait associations of microglial subsets
“The statistical test used was an unpaired t test with a two tailed p value.”
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,157
Single-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Self-citationJansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277
Adult mouse cortical cell taxonomy revealed by single cell transcriptomics
Tasic, B., Menon, V., Nguyen, T. N., Kim, T. K., Jarsky, T., Yao, Z., Levi, B., Gray, L. T., Sorensen, S. A., Dolbeare, T., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4216 · Cited by 1,714
Self-citationDOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis
Yu, G., Wang, L.-G., Yan, G.-R., & He, Q.-Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu684 · Cited by 1,274
Cited by
Microglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
Self-citationThe Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Morris, E. C., Neelapu, S. S., Giavridis, T., & Sadelain, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00547-6 · Cited by 1,104
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
Metadata
- Authors
- Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., Grün, D., Kroshilina, A. A., Dionne, D., Sarkis, R. A., Cosgrove, G. R., Helgager, J., Golden, J. A., Pennell, P. B., Prinz, M., Vonsattel, J. P. G., Teich, A. F., Schneider, J. A., Bennett, D. A., Regev, A., Elyaman, W., Bradshaw, E. M., & De Jager, P. L.
- Affiliations
- Broad Institute (US)
- Columbia University Irving Medical Center (US)
- University of Freiburg (DE)
- Max Planck Institute of Immunobiology and Epigenetics (DE)
- Brigham and Women's Hospital (US)
- Rush University Medical Center (US)
- ORCID
- Olah, Marta
- Menon, Vilas
- Habib, Naomi
- Taga, Mariko F.
- Ma, Yiyi
- Cimpean, Maria
- Khairallah, Anthony
- Sankowski, Roman
- Grün, Dominic
- Dionne, Danielle
- Sarkis, Rani A.
- Cosgrove, Garth R.
- Golden, Jeffrey A.
- Pennell, Page B.
- Prinz, Marco
- Teich, Andrew F.
- Schneider, Julie A.
- Bennett, David A.
- Regev, Aviv
- Elyaman, Wassim
- Bradshaw, Elizabeth M.
- De Jager, Philip L.
- Venue
- Nature Communications
- Published
- 2020-11-30
- Volume
- 11
- Issue
- 1
- Pages
- 6129-6129
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC7704703
- OpenAlex
- W3109942090
- Semantic Scholar
- 9ede0419da3c5670071f40c76ffeb53d1a55ac92
- Cited by
- 722
- References
- 41
- Citations by year
- 2026: 136 · 2025: 125 · 2024: 158 · 2023: 122 · 2022: 104 · 2021: 75
- FWCI
- 30.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- Alzheimer’s Association (AARF-17-505638)
- U.S. Department of Health & Human Services | NIH | Center for Scientific Review (AG046152, AG036836, AG048015, AG057473, NS089674)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- microglia, microglial heterogeneity, Alzheimer's disease, human cerebral cortex, microglial subpopulations, single-cell transcriptomics, single-nucleus RNA sequencing, neuroinflammation
- MeSH terms
- Alzheimer Disease, Cerebral Cortex, Female, Humans, Male, Sequence Analysis, RNA, Microglia, Myeloid Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41467-020-19737-2
- The paper
- Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., Grün, D., Kroshilina, A. A., Dionne, D., Sarkis, R. A., Cosgrove, G. R., Helgager, J., Golden, J. A., Pennell, P. B., Prinz, M., . . . De Jager, P. L. (2020). Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. Nature Communications. https://doi.org/10.1038/s41467-020-19737-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.